Ginkgo Bioworks
DNA
DNA
312 hedge funds and large institutions have $312M invested in Ginkgo Bioworks in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 67 increasing their positions, 111 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 72
40% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 111
79% less capital invested
Capital invested by funds: $1.51B → $312M (-$1.19B)
Holders
312
Holding in Top 10
2
Calls
$1.09M
Puts
$1.02M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$6.45M | |
| 3 | +$5.77M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.19M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$5.09M |
Top Sellers
| 1 | -$55.4M | |
| 2 | -$33M | |
| 3 | -$17.8M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$17.7M |
| 5 |
Morgan Stanley
New York
|
-$14.4M |